The Gut Microbiota and Liver Disease
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2015/05/01
-
Indian UGC (journal)
-
Refrences117
-
Citations120
-
Cristina Llorente
-
Bernd Schnabl
Cite
Llorente, Cristina, and Bernd Schnabl. “The Gut Microbiota and Liver Disease”. Cellular and Molecular Gastroenterology and Hepatology, vol. 1, no. 3, 2015, pp. 275-84, https://doi.org/10.1016/j.jcmgh.2015.04.003.
Llorente, C., & Schnabl, B. (2015). The Gut Microbiota and Liver Disease. Cellular and Molecular Gastroenterology and Hepatology, 1(3), 275-284. https://doi.org/10.1016/j.jcmgh.2015.04.003
Llorente C, Schnabl B. The Gut Microbiota and Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 2015;1(3):275-84.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the digestive system
Gastroenterology
Medicine
Medicine (General)
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host–microbial interactions | Proceedings of the National Academy of Sciences |
| 884 | 2011 |
| Supplementation of Saturated Long-Chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice | Gastroenterology |
| 217 | 2015 |
Dysbiosis‐induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice | Hepatology |
| 213 | 2015 |
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk | Alcoholism: Clinical and Experimental Research | 194 | 2015 | |
| Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice | The FASEB Journal |
| 125 | 2015 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology 45
is the most frequently represented among the references in this article. It primarily includes studies from Nature The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Gut microbial dysbiosis in the pathogenesis of leukemia: an immune-based perspective | Experimental Hematology |
| 2024 | |
| S-amlodipine induces liver inflammation and dysfunction through the alteration of intestinal microbiome in a rat model | Gut Microbes |
| 2024 | |
The artificial sweetener neotame negatively regulates the intestinal epithelium directly through T1R3-signaling and indirectly through pathogenic changes to model gut bacteria | Frontiers in Nutrition |
| 2024 | |
Biomolecular Actions by Intestinal Endotoxemia in Metabolic Syndrome | International Journal of Molecular Sciences |
| 2024 | |
The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota | Life |
| 1 | 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 39
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Neue Therapieoptionen für die Leberfibrose and was published in 2015. The most recent citation comes from a 2024 study titled The artificial sweetener neotame negatively regulates the intestinal epithelium directly through T1R3-signaling and indirectly through pathogenic changes to model gut bacteria. This article reached its peak citation in 2017, with 19 citations. It has been cited in 93 different journals, 23% of which are open access. Among related journals, the Scientific Reports cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.